GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cassava Sciences Inc (MEX:SAVA) » Definitions » Beneish M-Score

Cassava Sciences (MEX:SAVA) Beneish M-Score : 0.00 (As of Jun. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cassava Sciences Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Cassava Sciences's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of Cassava Sciences was 4.98. The lowest was 3.73. And the median was 4.36.


Cassava Sciences Beneish M-Score Historical Data

The historical data trend for Cassava Sciences's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cassava Sciences Beneish M-Score Chart

Cassava Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cassava Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cassava Sciences's Beneish M-Score

For the Biotechnology subindustry, Cassava Sciences's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cassava Sciences's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cassava Sciences's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Cassava Sciences's Beneish M-Score falls into.



Cassava Sciences Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Cassava Sciences for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * +0.528 * +0.404 * +0.892 * +0.115 *
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * +4.679 * -0.327 *
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was MXN16.60 Mil.
Revenue was 0 + 0 + 0 + 0 = MXN0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = MXN0.00 Mil.
Total Current Assets was MXN2,223.88 Mil.
Total Assets was MXN2,584.34 Mil.
Property, Plant and Equipment(Net PPE) was MXN358.55 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN24.74 Mil.
Selling, General, & Admin. Expense(SGA) was MXN270.07 Mil.
Total Current Liabilities was MXN1,279.92 Mil.
Long-Term Debt & Capital Lease Obligation was MXN0.00 Mil.
Net Income was 415.62 + -355.084 + -446.812 + -452.188 = MXN-838.46 Mil.
Non Operating Income was 716.975 + 4.94 + 3.884 + 3.48 = MXN729.28 Mil.
Cash Flow from Operations was -317.437 + -378.797 + -462.123 + -341.575 = MXN-1,499.93 Mil.
Total Receivables was MXN0.00 Mil.
Revenue was 0 + 0 + 0 + 0 = MXN0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = MXN0.00 Mil.
Total Current Assets was MXN3,514.86 Mil.
Total Assets was MXN3,931.45 Mil.
Property, Plant and Equipment(Net PPE) was MXN407.53 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN26.68 Mil.
Selling, General, & Admin. Expense(SGA) was MXN259.64 Mil.
Total Current Liabilities was MXN250.71 Mil.
Long-Term Debt & Capital Lease Obligation was MXN0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(16.596 / 0) / (0 / 0)
= /
=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0 / 0) / (0 / 0)
= /
=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2223.882 + 358.545) / 2584.336) / (1 - (3514.857 + 407.527) / 3931.451)
=0.000739 / 0.002306
=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0 / 0
=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(26.681 / (26.681 + 407.527)) / (24.735 / (24.735 + 358.545))
=0.061448 / 0.064535
=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(270.071 / 0) / (259.644 / 0)
= /
=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 1279.92) / 2584.336) / ((0 + 250.71) / 3931.451)
=0.495261 / 0.06377
=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-838.464 - 729.279 - -1499.932) / 2584.336
=-0.026239

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.


Cassava Sciences Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Cassava Sciences's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Cassava Sciences (MEX:SAVA) Business Description

Traded in Other Exchanges
Address
6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.